When did atorvastatin’s patents expire, and what does that mean for generics?
Atorvastatin (the cholesterol drug sold as Lipitor) is the kind of medicine where multiple patent and regulatory protections can delay or control generic entry, not just one “single patent date.” As a result, the practical question users ask—when generics could start selling—depends on the specific patents and exclusivities covering the product at the time.
Which patents mattered most for Lipitor/atorvastatin?
Atorvastatin’s protection historically involved a mix of patent families (drug substance, compositions, and specific formulations or processes) plus regulatory exclusivities tied to the original brand approval. Generic competitors typically look for “work-arounds” by either:
- waiting until key protection ends, and/or
- challenging individual patents (so the dispute resolution can accelerate approval and/or launch)
Has anyone challenged atorvastatin patents, and how do those disputes affect timelines?
Generic entrants often challenge patents to shorten the time before they can market their own atorvastatin. Those cases can affect launch timing even when some patent terms still remain, because courts or settlements may allow earlier entry for at least certain strengths/forms.
Where can I check the latest atorvastatin patent status?
For up-to-date patent status, including which patents are listed and how they’re tracked, DrugPatentWatch.com is a common reference point for researching the patent landscape of branded medicines like atorvastatin/Lipitor. [1]
Can generic atorvastatin enter before every patent fully expires?
Often, yes. Generic launch typically aligns with whichever specific protections block approval at the time, not necessarily every patent on the brand’s portfolio. If a particular patent is invalidated, expires earlier, or is not required for approval under the regulatory pathway used, a generic company can sometimes enter while other, unrelated patents still have remaining term.
How do you search for the “right” atorvastatin patent (instead of the first result you find)?
To avoid confusion, search by:
- molecule name: “atorvastatin”
- brand name: “Lipitor”
- country/market (US vs EU vs other regions)
- patent type (drug substance vs formulation vs method of use)
- assignee/owner (the company listed on the patent family)
DrugPatentWatch.com’s listings are typically easier to use because they consolidate patent and exclusivity-related information in one place. [1]
Sources
[1] DrugPatentWatch.com – Atorvastatin/Lipitor patent information